The DOI matches its Crossref record; 239 of the 241 references it cites were found in a registry or an index.
The clinical implications of ageing for rational drug therapy
Abstract
Introduction The proportion of the elderly is constantly increasing and by the year 2025 20% of the population will be above 65 years of age. With advanced age, subjects will develop multiple diseases and often need to take several drugs.Discussion This polypharmacy increases the risk for drug interactions and adverse effects. In addition, age-related physiological changes affect different biological systems and can contribute to alterations in pharmacokinetics and pharmacodynamics in older patients, which are more often seen in the frail than in the fit elderly. These features will complicate drug therapy in the elderly, and a careful dose titration is advisable. Furthermore, inappropriate drug prescription and non-adherence to medication represent common therapeutic challenges in elderly subjects. To date, there is no evidence of any effective antiageing agent.Conclusion This review summarizes present knowledge of age-related problems in drug action and their clinical implications for an increasingly important population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Older adults show greater sensitivity to drugs acting upon the central nervous system and their side effects [11, 12].”
From Stakeholders' views on the use of psychotropic medication in older people: a systematic review (2022) · cites this paper as [11]
Citations
Cites
1 retracted
Items 201–239 of 239
The elderly—a challenge for appropriate drug treatment
Klotz, U. E. (2007) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0410-5 · Cited by 21
Self-citationLatest advances in antiaging medicine
Grossman, T. (2005) · The Keio Journal of Medicine · doi:10.2302/kjm.54.85 · Cited by 19
Groen, K., Horan, M. A., Roberts, N. A., Gulati, R. S., Miljković, B., Jansen, E. J., Paramsothy, V., Breimer, D. D., & van Bezooijen, C. F. A. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199325020-00006 · Cited by 18
Aging Does not Affect Beta‐Agonist Responsiveness after Methacholine‐Induced Bronchoconstriction
Parker, A. L. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52110.x · Cited by 17
Villoria, C. M., Garrote, J. M. P.-C., Sánchez‐Magro, I., & Álvarez, M. N. (2007) · Medicina Clínica · doi:10.1157/13098717 · Cited by 17
Pharmacokinetics and pharmacodynamics in the elderly.
Lichtman, S. M. (2007) · PubMed · Cited by 16
Polypharmacy and older people.
Bretherton, A., Day, L., & Lewis, G. (2003) · PubMed · Cited by 15
Factors influencing Noncompliance with Medication Regimens in the Elderly.
Kuzuya, M., Endo, H., Umegaki, H., Nakao, M., Niwa, T., Kumagai, T., Ushida, Y., Nabeshima, T., & Iguchi, A. (2000) · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics · doi:10.3143/geriatrics.37.363 · Cited by 15
Varas‐Lorenzo, C., de Castro, A. M. R., Maguire, A., & Miret, M. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1229 · Cited by 14
Influence of aging on the oxidative and conjugative metabolism of propranolol.
Tateishi, T., Fujimura, A., Shiga, T., Ohashi, K., & Ebihara, A. (1995) · PubMed · Cited by 14
Summerbell, J., Wynne, H., Hankey, C., & Williams, F. M. (1993) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1993.tb00387.x · Cited by 14
Pharmacodynamics in the elderly.
JACKSON, S. (1994) · PubMed · Cited by 13
Nomura, K., Nakao, M., Sato, M., & Yano, E. (2007) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.212.239 · Cited by 13
Introduction: Anti-Aging Medicine: The Hype and the Reality--Part I
Olshansky, S. J., Hayflick, L., & Perls, T. T. (2004) · The Journals of Gerontology Series A · doi:10.1093/gerona/59.6.b513 · Cited by 12
Introduction: Anti-Aging Medicine: The Hype and the Reality--Part II
Olshansky, S. J., Hayflick, L., & Perls, T. T. (2004) · The Journals of Gerontology Series A · doi:10.1093/gerona/59.7.b649 · Cited by 12
Age-related alteration of haloperidol–serum protein binding
Koyama, H., Mori, S., Sugioka, N., Nishihara, T., & Nakajima, K. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2003.tb02436.x · Cited by 10
Topinková, E., Fialová, D., Carpenter, G., & Bernabei, R. (2006) · PubMed · Cited by 9
Effets indésirables des médicaments chez les sujets âgés
Doucet, J., & Queneau, P. (2005) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)33427-2 · Cited by 9
[Pitfalls of polypharmacy, particularly in the elderly].
Queneau, P. (2006) · PubMed · Cited by 8
[How to improve estimation of renal function in the elderly].
Froissart, M., & Rossert, J. (2005) · PubMed · Cited by 8
Age-Related Changes in Pharmacokinetics and Pharmacodynamics: A Review
Tobias, D. E. (2004) · The Consultant Pharmacist · doi:10.4140/tcp.n.2004.736 · Cited by 8
[Prescription drugs and the elderly: results of the Argento study].
Pizzuti, R., Caffari, B., & BINKIN, N. J. (2007) · PubMed · Cited by 8
Drug-related hospital admissions--an overview of frequency and clinical presentation.
Jenerowicz, D., Czarnecka-Operacz, M. M., Górecka, A., & Stawny, M. (2006) · PubMed · Cited by 8
[Drug compliance in the elderly: determinants and support].
Schneider, M.-P., Locca, J.-F., Bugnon, O., & Conzelmann, M. (2006) · PubMed · Cited by 7
Single-dose pharmacokinetics of cefodizime in critically ill elderly patients
MEYER, B., Traunmüller, F., Bojic, A., Locker, G. J., Schmid, R. M., Winkler, S., & Thalhammer, F. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.11.018 · Cited by 6
Alpha 1-adrenoceptor responsiveness: the influence of age.
Elliott, H. L. (1988) · PubMed · Cited by 6
Climente, I. P. P., Sandomingo, V. O. D. U., Escoto, I. P., Vargas, I. Q., Miralles, A. M., & Martínez, M. M. (2007) · Farmacia Hospitalaria · doi:10.1016/s1130-6343(07)75721-5 · Cited by 6
Medication management in the elderly.
Stratton, M. A., & Salinas, R. C. (2003) · PubMed · Cited by 6
[Falls in hospitalized elderly patients: incidence and risk factors].
Zanocchi, M., Pilon, S., Speme, S., Nicola, E., Corsinovi, L., Ponte, E., Cerrato, F., Luppino, A. F., Martinelli, E., Margolicci, A., et al. (2004) · PubMed · Cited by 5
¿Se hace un buen uso de las benzodiazepinas en el anciano?
Barberá, T., Avellana, J. A., & Moreno, L. (2007) · Revista Clínica Española · doi:10.1157/13100229 · Cited by 5
Detección del riesgo de caídas en ancianos en atención primaria mediante un protocolo de cribado
Prat-González, I., Fernández-Escofet, E., & Martínez-Bustos, S. (2007) · Enfermería Clínica · doi:10.1016/s1130-8621(07)71783-7 · Cited by 4
[Characterizing the prescription of non-steroidal anti-inflammatory drugs among the elderly].
Lagunes-Espinosa, A. L., Peralta‐Pedrero, M. L., Rodríguez‐Moctezuma, J. R., López-Carmona, J. M., Ibarra-Vicens, E., Cruz-Avelar, A., & Munguía-Miranda, C. (2007) · PubMed · Cited by 3
González‐Juanatey, J. R., Rivera, J., Sánchez, R. G., Reviriego, B., & Casimiro, C. (2006) · Anales de Medicina Interna · doi:10.4321/s0212-71992006000900005 · Cited by 3
[Assessing renal function in elderly people].
Maftei, I.-D., Cepoi, V., & Covic, A. (2007) · PubMed · Cited by 3
α1-Adrenoceptor Responsiveness
Elliott, H. L. (1988) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198812081-00025 · Cited by 3
Polypharmacy and Adverse Drug Reactions
Babbar, J. (2007) · Psychiatric Services · doi:10.1176/appi.ps.58.7.1011 · Cited by 2
Osman, E. S., Khafagy, H. F., Radwan, K. G., & Desouky, A. M. (2007) · PubMed · Cited by 2
[Polypharmacy in elderly patients--the eternal problem. The Danish Geriatric Society].
Rosholm, J., & Holm, E. (2007) · PubMed · Cited by 1
Babbar, J. (2007) · Psychiatric Services · doi:10.1176/ps.2007.58.7.1011 · Cited by 1
Flagged first, then by citations
2 of the 241 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Kennerfalk A, Ruigómez A, Wallander MA, Wilhelmsen L, Johansson S (2002) Geriatric drug therapy and healthcare utilization in the United Kingdom. Ann Pharmacother 36:797–803 · DOI · Paper page
- Doucet J, Queneau P (2005) Adverse drug reactions in the elderly. Bull Acad Natl Med 189:1693–1707; discussion 1708–1709
- Björkman IK, Fastbom J, Schmidt IK, Bernsten CB; Pharmaceutical Care of the Elderly in Europe Research (PEER) Group (2002) Drug-drug interactions in the elderly. Ann Pharmacother 36:1675–1681 · DOI · Paper page
- González-Juanatey JR, Rivera J, Gabriel Sánchez R, Reviriego Almohalla B, Casimiro C (2006) Effects of NSAID on blood pressure among hypertensive patients with a high cardiovascular risk. An Med Intern 23:420–427
Cited by
Sorted by citations
Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations
Fisher, M., Feuerstein, G., Howells, D. W., Hurn, P. D., Kent, T. A., Savitz, S. I., & Lo, E. H. (2009) · Stroke · doi:10.1161/strokeaha.108.541128 · Cited by 1,352
Pharmacokinetics and drug metabolism in the elderly
Klotz, U. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530902722679 · Cited by 826
Self-citationPotentially Inappropriate Medications in the Elderly
Holt-Noreiks, S., Schmiedl, S., & Thürmann, P. (2010) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2010.0543 · Cited by 795
Age-Related Pharmacokinetic and Pharmacodynamic Changes and Related Risk of Adverse Drug Reactions
Corsonello, A., Pedone, C., & Incalzi, R. A. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790416326 · Cited by 402
The epidemiology of polypharmacy in older adults: register-based prospective cohort study
Morin, L., Johnell, K., Laroche, M., Fastbom, J., & Wastesson, J. W. (2018) · Clinical Epidemiology · doi:10.2147/clep.s153458 · Cited by 390
Metadata
- Authors
- Shi, S., Mörike, K., & Klotz, U.
- Affiliations
- Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology (DE)
- University of Tübingen (DE)
- Corresponding author
- Klotz, Ulrich
- ORCID
- Klotz, Ulrich
- Venue
- European Journal of Clinical Pharmacology
- Published
- 2008-01-05
- Volume
- 64
- Issue
- 2
- Pages
- 183-199
- ISSN
- 0031-6970 (ISSN-L)
- 1432-1041
- OpenAlex
- W2027764308
- Cited by
- 244
- References
- 241
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 11 · 2023: 9 · 2022: 10 · 2021: 13 · 2020: 14 · 2019: 15 · 2018: 14 · 2017: 12 · 2016: 15 · 2015: 23 · 2014: 15 · 2013: 21 · 2012: 18
- FWCI
- 1.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Clinical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Robert Bosch Stiftung
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Keywords
- aging, older adults, polypharmacy, drug interactions, adverse drug reactions, age-related physiological changes, pharmacokinetics, pharmacodynamics, frail elderly, dose titration, inappropriate prescribing, medication non-adherence
- MeSH terms
- Aged, Aging, Drug Therapy, Humans, Pharmacokinetics, Practice Patterns, Physicians', Risk Factors, Comorbidity, Treatment Refusal, Frail Elderly, Polypharmacy, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review